Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Sell
2,070
-400
-16% -$46.2K 0.2% 80
2025
Q4
$260K Buy
2,470
+10
+0.4% +$939 0.19% 83
2025
Q3
$206K Hold
2,460
0.14% 98
2025
Q2
$195K Buy
+2,460
New +$196K 0.14% 95
2024
Q3
$271K Hold
2,388
0.23% 80
2024
Q2
$296K Buy
+2,388
New +$308K 0.26% 74
2023
Q3
$257K Sell
2,498
-15
-0.6% -$1.62K 0.27% 73
2023
Q2
$290K Sell
2,513
-1,041
-29% -$118K 0.28% 67
2023
Q1
$378K Sell
3,554
-339
-9% -$36.6K 0.4% 51
2022
Q4
$432K Sell
3,893
-198
-5% -$20.2K 0.33% 61
2022
Q3
$352K Buy
4,091
+273
+7% +$24.4K 0.32% 63
2022
Q2
$348K Sell
3,818
-425
-10% -$37.7K 0.3% 61
2022
Q1
$348K Sell
4,243
-18
-0.4% -$1.42K 0.26% 71
2021
Q4
$327K Buy
4,261
+1,088
+34% +$86.7K 0.19% 91
2021
Q3
$238K Sell
3,173
-17
-0.5% -$1.29K 0.17% 92
2021
Q2
$248K Sell
3,190
-143
-4% -$10.6K 0.19% 77
2021
Q1
$245K Buy
+3,333
New +$246K 0.2% 80
2020
Q4
Sell
-3,684
Closed -$291K 103
2020
Q3
$291K Sell
3,684
-19,996
-84% -$1.57M 0.28% 62
2020
Q2
$2M Buy
+23,680
New +$1.78M 0.47% 42

Other funds holding MRK

WFA of San Diego's MRK Position: Q1 2026 in Review

WFA of San Diego reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $46.2K and leaving 2,070 shares worth $249K. The position accounts for 0.2% of the portfolio, ranked #80.

WFA of San Diego first reported a position in MRK in Q2 2020 and has held it in 19 quarters since. The position peaked at $2M in Q2 2020. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WFA of San Diego held 2,070 shares of Merck worth $249K as of Q1 2026.
  • WFA of San Diego sold 400 Merck shares in Q1 2026, an estimated $46.2K.
  • Merck made up 0.2% of WFA of San Diego's portfolio in Q1 2026, its #80 holding.
  • WFA of San Diego first reported a position in Merck in Q2 2020 and has held it in 19 quarters since.
  • WFA of San Diego's Merck position peaked at $2M in Q2 2020.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WFA of San Diego's 13F filing for Q1 2026, filed 11 May 2026.